Prophylactic Salpingo-Opphorectomy in Patients With Hereditary Predisposition Genes for Ovarian Cancer

Alison A Garrett¹, Haider Mahdi^{1

2

3}

Affiliations

¹ Magee Women's Hospital, University of Pittsburgh Medical Center, Pittsburgh, PA.
² Magee Women's Research Institute, University of Pittsburgh, Pittsburgh, PA.
³ Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA.

Comment

Alison A Garrett et al. JCO Oncol Pract. 2022 Jun.

. 2022 Jun;18(6):e846-e848.

doi: 10.1200/OP.22.00069. Epub 2022 Mar 8.

Alison A Garrett¹, Haider Mahdi^{1

2

3}

¹ Magee Women's Hospital, University of Pittsburgh Medical Center, Pittsburgh, PA.
² Magee Women's Research Institute, University of Pittsburgh, Pittsburgh, PA.
³ Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA.

No abstract available

Conflict of interest statement

Haider MahdiResearch Funding: Puma BiotechnologyNo other potential conflicts of interest were reported.

Risk-Reducing Bilateral Salpingo-Oophorectomy for Ovarian Cancer: A Review and Clinical Guide for Hereditary Predisposition Genes.
Liu YL, Breen K, Catchings A, Ranganathan M, Latham A, Goldfrank DJ, Grisham RN, Long Roche K, Frey MK, Chi DS, Abu-Rustum N, Aghajanian C, Offit K, Stadler ZK. Liu YL, et al. JCO Oncol Pract. 2022 Mar;18(3):201-209. doi: 10.1200/OP.21.00382. Epub 2021 Sep 28. JCO Oncol Pract. 2022. PMID: 34582274 Free PMC article. Review.

1. American Cancer Society . Cancer Facts & Figures 2021. Atlanta, GA: American Cancer Society; 2021.
1. Liu YL, Breen K, Catchings A, et al. Risk-reducing bilateral salpingo-oophorectomy for ovarian cancer: A review and clinical guide for hereditary predisposition genes JCO Oncol Pract 18201–2092022 - PMC - PubMed
1. Manchanda R, Legood R, Antoniou AC, et al. Specifying the ovarian cancer risk threshold of “premenopausal risk-reducing salpingo-oophorectomy” for ovarian cancer prevention: A cost-effectiveness analysis” J Med Genet 53591–5992016 - PubMed
1. Kuchenbaecker KB, Hopper JL, Barnes DR, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers JAMA 3172402–24162017 - PubMed
1. Eleje GU, Eke AC, Ezebialu IU, et al. Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations. Cochrane Database Syst Rev. 2018;8:CD012464. - PMC - PubMed